General practitioners and rare lung diseases: a task force for the development of rare lung diseases educational material

B. Balbi, D. Vallese, N. Chavannes, et al.

Source: Guideline 2017
Number: 2017

PDF journal article, handout or slides

Rating: 1
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Balbi, D. Vallese, N. Chavannes, et al.. General practitioners and rare lung diseases: a task force for the development of rare lung diseases educational material. Guideline 2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group
Source: Eur Respir J 2005; 26: Suppl. 49, 500s
Year: 2005

The best ERJ papers in interstitial and rare lung diseases
Source: International Congress 2018 – The best of the European Respiratory Journal in 2018
Year: 2018

Diagnosis of interstitial lung diseases and impact of guidelines: an issue only for pulmonologists?
Source: Annual Congress 2007 - Controversies in the management of interstitial lung diseases
Year: 2007

Smoking-related lung diseases: a clinical perspective
Source: Eur Respir J 2010; 35: 231-233
Year: 2010

How consistently do physicians diagnose and manage drug-induced interstitial lung disease? Two surveys of European ILD specialist physicians
Source: ERJ Open Res, 6 (1) 00286-2019; 10.1183/23120541.00286-2019
Year: 2020

Teleradiology in interstitial lung disease: first experiences
Source: International Congress 2017 – Rare diseases
Year: 2017

The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective
Source: International Congress 2019 – Rare lung diseases
Year: 2019

Clinical highlights from the 2011 ERS Congress in Amsterdam
Source: Eur Respir J 2012; 39: 1501-1510
Year: 2012

Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Rare lung diseases in children: challenges for diagnosis and treatment
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021

The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015

Occupational lung disorders of the parenchyma: important points for clinicians
Source: ISSN=ISSN 1810-6838, ISBN=, page=33
Year: 2007

A comparison of existing questionnaires for identifying the causes of interstitial and rare lung diseases
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019

Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology
Source: Eur Respir Rev 2013; 22: 117-123
Year: 2013

The internet-based network for the management of children with interstitial lung disease
Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease
Year: 2014

EPIDIA: an App to to assist physicians in the care of patients with interstitial lung diseases
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021

Contemporary challenges for specialist nursing in interstitial lung disease
Source: Breathe, 14 (1) 36; 10.1183/20734735.014917
Year: 2018

Where are the gaps in education in the field of rare lung disease? Perspectives from the ERN-LUNG educational programme survey
Source: Breathe, 15 (2) 102; 10.1183/20734735.0120-2019
Year: 2019